Physiologically‐Based Pharmacokinetic Modelling of Creatinine‐Drug Interactions in the Chronic Kidney Disease Population-Reference-Cited by-同舟云学术

Physiologically‐Based Pharmacokinetic Modelling of Creatinine‐Drug Interactions in the Chronic Kidney Disease Population

Published:2020-11-23 Issue:12 Volume:9 Page:695-706
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Takita Hiroyuki¹²^ORCID,Scotcher Daniel¹^ORCID,Chinnadurai Rajkumar³⁴^ORCID,Kalra Philip A.³⁴^ORCID,Galetin Aleksandra¹^ORCID

Affiliation:

1. Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

2. Laboratory for Safety Assessment and ADME, Pharmaceuticals Research Center Asahi Kasei Pharma Corporation Shizuoka Japan

3. Department of Renal Medicine Salford Royal NHS Foundation Trust Salford UK

4. Faculty of Biology Medicine and Health University of Manchester Manchester UK

Funder

Asahi Kasei Pharma Corporation

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12566

Reference48 articles.

1. A New Equation to Estimate Glomerular Filtration Rate

2. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

3. Tubular secretion of creatinine and kidney function: an observational study;Zhang X.;BMC Nephrol.,2020

4. Measurement error as alternative explanation for the observation that CrCl/GFR ratio is higher at lower GFR;Zhang X.;Clin. J. Am. Soc. Nephrol.,2016

5. The Effect of Uremic Solutes on the Organic Cation Transporter 2

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective;Clinical Pharmacokinetics;2024-06

2. Triglyceride-Glucose Index and Its Correlates: Associations with Serum Creatinine and Estimated Glomerular Filtration Rate in a Cross-Sectional Study from CHARLS 2011–2015;Metabolic Syndrome and Related Disorders;2023-12-22

3. Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease;Pharmaceutical Research;2023-09-13

4. Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney Dysfunction;DRUG METAB DISPOS;2023

5. 50th Anniversary Celebration Collection Special Section on Mechanism-Based Predictive Methods in Drug Discovery and Development-Minireview Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition^S;DRUG METAB DISPOS;2023